Pink eye, also known as conjunctivitis, is a common and highly contagious eye infection characterized by inflammation of the conjunctiva – the thin, clear tissue that lines the inside of the eyelid and covers the whites of the eyes. This condition earns its name due to the telltale symptom it presents: reddish or pink discoloration in one or both eyes. Pink eye can be caused by several factors including bacterial or viral infections, allergies, irritants like smoke or chemicals, and even certain sexually transmitted diseases. Regardless of its origins, pink eye typically manifests with uncomfortable symptoms such as itching, burning sensations, excessive tearing, or discharge which may lead to crusting around the eyes. While proper hygiene practices such as handwashing and avoiding touching your face can help prevent this ailment from spreading further among individuals in close proximity – particularly in places like schools or offices where transmission is swift – timely medical intervention remains crucial to alleviate discomfort and prevent prolonged recuperation periods associated with this common ocular affliction.
1.
enhancing survivors of brain tumors' quality of life.
2.
Browse the NBE-Released Curriculum at FNB Head and Neck Oncology.
3.
A protein with new anticancer activity has been identified
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Enzalutamide vs Abiraterone: Which is Better for mCSPC?
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
Future of Chemotherapy: New Advances, Treatments & Survival Rates Transforming Cancer Care
3.
What is Hemorrhagic Cystitis and How to Manage its Symptoms
4.
Fc Receptor Mediated Pharmacology of Therapeutic Antibodies
5.
Progressive Strategies in Oncology and Patient Outcomes
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
4.
Managing Common Side Effects During Cancer Treatment
5.
Clinical Insights in Oncology
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation